The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat

Neuroscience Letters

Volumn 362, Issue 3, 2004, Pages 240-243

  Mikkelsen, Jens D ^a  

^a NEUROSEARCH A S   (Denmark)

Author keywords

Anti psychotics; Dopamine; Ion channel; Rat

Indexed keywords

HALOPERIDOL; INWARDLY RECTIFYING POTASSIUM CHANNEL; MEMBRANE PROTEIN; POTASIUM CHANNEL KCNQ STIMULATING AGENT; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN C FOS; RETIGABINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN REGION; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; INHIBITION KINETICS; MALE; NERVE CELL; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; REVIEW; UPREGULATION;

EID: 2442614669     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.025     Document Type: Article

References (20)

1. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271
2. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101
3. Blackburn-Munro G., Jensen B.S. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur. J. Pharmacol. 460:2003;109-116
4. Cooper E.C., Harrington E., Jan Y.N., Jan L.Y. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J. Neurosci. 21:2001;9529-9540
5. Gribkoff V.K. The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin. Ther. Targets. 7:2003;737-748
6. Hussain N., Flumerfelt B.A., Rajakumar N. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience. 102:2001;391-399
7. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 1:2000;21-30
8. Kharkovets T., Hardelin J.P., Safieddine S., Schweizer M., El-Amraoui A., Petit C., Jentsch T.J. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. USA. 97:2000;4333-4338
9. Korsgaard M.P.G., Herrik K.F., Brown W.D., Christophersen P., Strøbæk D. Flupirtine activates KCNQ channels. Biophys. J. S84:2003;547a
10. Ljungstrom T., Grunnet M., Jensen B.S., Olesen S.P. Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels. Pflug. Arch. 446:2003;684-694
11. J.D. Mikkelsen, C. Ebbesen, T. Kharkovets, C. Rosenblad, S. Aznar, T.J. Jentsch, B.S. Jensen, L.-C. Rønn, KCNQ4 containing channels are expressed in ascending monoaminergic neurons of the rat, 33rd Annual Meeting of the Society for Neuroscience, 2003, 368.10.
12. Mikkelsen J.D., Vrang N., Mrosovsky N. Expression of Fos in the circadian system following nonphotic stimulation. Brain Res. Bull. 47:1998;367-376
13. Nordstrom A.L., Farde L., Wiesel F.A., Forslund K., Pauli S., Halldin C., Uppfeldt G. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol. Psychiatry. 33:1993;227-235
14. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328
15. Rogawski M.A. KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 23:2000;393-398
16. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E.E., Kutscher B., Loscher W., Honack D., White H.S., Wolf H.H. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 23:1996;211-223
17. Schmidt W.J., Schuster G., Wacker E., Pergande G. Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs. Eur. J. Pharmacol. 327:1997;1-9
18. Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C., Jentsch T.J. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem. 275:2000;24089-24095
19. Tatulian L., Delmas P., Abogadie F.C., Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 21:2001;5535-5545
20. Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. 58:2000;591-600